Alzheimer / AbMart Inc. / CML / Molecular Epigenetics Laboratory / Cox / Shunjian Pharmaceuticals Inc. / DDP Report 2013 Drug Discovery Pipeline / /
Continent
North America / /
Country
China / /
Currency
pence / USD / /
Event
Business Partnership / FDA Phase / /
Facility
pipeline The / pipeline Candidate Compounds / Health Drug Discovery Pipeline / /
IndustryTerm
surface plasmon resonance using chips / mammalian cell expression systems / technology labs / treatment of resistant forms of chronic myelogenous leukemia / chemical library / pharmaceutical / brand-new lab site / internal chemical library / technology groups / stateof-the-art equipment / treatment of various blood disorders / treatment of Alzheimer’s disease / chemical entities / treatment of various cancers / chemical entities targeting pathways / chemical analysis / treatment of chronic myeloid leukemia / /
driver / Crystallography Biology Leader Chemistry Leader / General / head / Department Head / Research Project Leader / Executive / adjuvant arthritis model for screening anti-inflammatory based drugs / Research Project Team Research Project Leader / Candidate / /
Product
Gleevec / donepezil / Inh / T315I / /
PublishedMedium
Analytical Chemistry / /
RadioStation
Core / /
Region
Southern China / /
Technology
alpha / genomics / drug metabolism / X-ray / antibodies / High-Throughput Screening / ultrasound / drug screening / Pharmacokinetics / pathway mapping / Drug Discovery / epigenomics / gene targeting / drug design / surface plasmon resonance using chips / Pharmacodynamics / drug development / /
Guangzhou Institutes of Biomedicine and Health Drug Discovery Pipeline (DDP): Report 2014 Executive Summary Micky Tortorella[removed]